Huiquan Medical Leverages 3D Printing to Deliver End-to-End Surgical Solutions

3D printing technology has become deeply integrated into the medical field, attracting a large number of professionals to engage in it.

Huiquan Medical is one such innovative enterprise.

In an exclusive interview with VCBeat, Professor Zheng Minghui, founder of Huiquan Medical, stated that medical procedures are critical to patients' lives, soHuiquan Medical specializes in providing comprehensive digital surgical solutions and instrument services, covering surgical planning, preoperative simulation, intraoperative procedures, and postoperative recovery, with a pursuit of ultimate precision at every stage.。

3D Printing Technology in Medical Applications Is Divided into Three Stages:Preoperative Planning and Surgical Simulation, Intraoperative Procedures, Postoperative Rehabilitation.Preoperatively, 3D printing is utilized to construct physical models of patient organs, assisting surgeons in rehearsing procedures and optimizing surgical plans; intraoperatively, surgical guides facilitate precise resection localization, while customized implants accurately replicate patient-specific bone morphology for implantation—although bioprinting remains in the experimental stage, it holds broad prospects; postoperatively, rehabilitation braces, training, and assessment systems provide support for patient recovery.

In clinical practice, the Huiquan Medical workflow is initiated once patients complete their imaging examinations. The team first collects data to obtain clinical information, then employs specialized software for 3D reconstruction and design, including organ reconstruction targeted at lesions and specific needs, as well as the design of customized surgical guides and prostheses. Upon completion of modeling, the organ models, surgical guides, and prostheses undergo optimization and verification to ensure compliance with medical, surgical, and product performance requirements, before proceeding to the 3D printing manufacturing stage. During printing, optimal materials are selected based on clinical needs, such as titanium alloys for customized implantable prostheses and polymer materials for surgical guides, with strict control over production processes. Post-printing treatments, including cleaning and curing, are performed to enhance surface quality and mechanical properties. Quality monitoring is critical; the team rigorously tests the dimensional accuracy, surface quality, and mechanical properties of the printed products to ensure they meet clinical requirements.

Currently, significant achievements have been made in the applications within orthopedics, oral and maxillofacial surgery, and cardiology. In orthopedics, precise surgical guidance is provided for complex cases such as pelvic fractures and scoliosis; in oral and maxillofacial surgery, it supports orthognathic and plastic surgeries; in cardiology, 3D reconstruction enables physicians to accurately obtain information on cardiac defects and formulate more precise surgical plans.

From patient admission to product implantation, the entire process forms a continuous improvement cycle. Clinical application feedback serves as a valuable resource for the team to optimize technology and services. This closed loop, spanning from data collection to continuous improvement, enables the provision of safer, more effective, and personalized medical services for patients.

Within the ecosystem established by Huiquan Medical, multiple stakeholders—including universities and hospitals—collaborate closely to jointly advance medical technology. While pursuing independent research and development, Huiquan Medical actively engages in external partnerships, leveraging resource integration and complementary strengths to enhance its innovation capabilities and product competitiveness.

To address the high costs of 3D-printed medical devices and the substantial expenses associated with maintenance and upgrades, Huiquan Medical has collaborated with universities and enterprises such as Guangzhou Huarui Medical Device Co., Ltd. (affiliated with South China University of Technology) to jointly develop medical-grade 3D printing resins and ceramic bone materials for clinical applications. Furthermore, plans are underway to develop biological 3D printers and medical-grade Fused Filament Fabrication (FFF) 3D printers. These initiatives not only reduce procurement costs for healthcare institutions but also enhance the quality and precision of printed products, thereby providing more reliable support for clinical applications.

In the field of material research and development, Huiquan Medical has achieved remarkable results.Its polymer material (3D printing resin) has obtained certification; this material exhibits favorable biological properties and good mechanical properties, demonstrating significant potential for applications in the medical field.. Through 3D printing, it can be fabricated into various instruments and tools to provide patients with more personalized and precise treatment plans.

Furthermore, Huiquan Medical has keenly identified the transformative opportunities arising from the integration of generative artificial intelligence (AI) and 3D printing. Generative AI can expand material and functional capabilities, unlock the potential for multi-material and multifunctional printing, and optimize novel material combinations. Meanwhile, the collaborative nature of 3D printing will be enhanced by advancements in generative AI, driving progress in distributed manufacturing and facilitating the creation of customized, personalized 3D-printed products tailored to customer preferences. Zheng Minghui stated,In the future, Huiquan Medical will introduce self-developed AI-driven optimization to enhance the performance and efficiency of its 3D-printed medical devices, thereby providing patients with higher-quality and more efficient medical services.

In the interview, Zheng Minghui emphasized that 3D-printed digital medical centers hold immense potential and value in public hospitals. Faced with vast market demand,Huiquan Medical maintains close ties with hospitals through project collaborations and joint development initiatives, meeting their demands for 3D-printed medical equipment.

Under the project collaboration model, Huiquan Medical provides tailored 3D printing solutions based on the specific needs of hospitals, enabling them to access comprehensive services supported by a professional team. The joint construction model involves the shared development of equipment and resources, thereby enhancing the efficiency of medical resource utilization. Furthermore, Huiquan Medical has established an R&D service platform to assist clinicians in conducting research projects, publishing industry-academia-research papers, and applying for patents, thus facilitating the transformation of clinical intellectual property into tangible outcomes.

Regarding the differences between public and private hospitals, Zheng Minghui pointed out that public hospitals have advantages in process management and medical record quality, while private hospitals need to focus more on service and precision medicine. Huiquan Medical is currently negotiating collaborations with multiple public and private hospitals to expand its market share and influence.

As a partner, Chen Yiqun of Shangjun Investment stated that although the concept of 3D printing has been proposed for many years, its large-scale application has only begun in recent years. With its extensive promotion in clinical practice, the market space and application prospects are becoming increasingly broad. Shangjun Investment values Huiquan Medical’s philosophy of starting from clinical and patient needs, and will fully support its development, including addressing issues such as financing, brand building, international exchanges, and supporting market resources.